The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis
- PMID: 36415483
- PMCID: PMC9672617
- DOI: 10.1186/s42269-022-00955-1
The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis
Abstract
Background: Several reports of unheeded complications secondary to the current mass international rollout of SARS-COV-2 vaccines, one of which is myocarditis occurring with the FDA fully approved vaccine, Pfizer, and others.
Main body of the abstract: Certain miRNAs (non-coding RNA sequences) are involved in the pathogenesis in viral myocarditis, and those miRNAs are interestingly upregulated in severe COVID-19. We hypothesize that the use of mRNA-based vaccines may be triggering the release of host miRNAs or that trigger the occurrence of myocarditis. This is based on the finding of altered host miRNA expression promoting virus-induced myocarditis.
Short conclusion: In conclusion, miRNAs are likely implicated in myocarditis associated with mRNA vaccines. Our hypothesis suggests the use of miRNA as a biomarker for the diagnosis of mRNA vaccine-induced myocarditis. Additionally, the interplay between viral miRNA and the host immune system could alter inflammatory profiles, hence suggesting the use of therapeutic inhibition to prevent such complications.
Keywords: Micro-RNA; Myocarditis; Sarcopenia; mRNA COVID-19 vaccines.
© The Author(s) 2022.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
Similar articles
-
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34237049 Free PMC article.
-
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17. Rev Med Virol. 2022. PMID: 34921468 Review.
-
Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine.Cureus. 2022 Jul 7;14(7):e26650. doi: 10.7759/cureus.26650. eCollection 2022 Jul. Cureus. 2022. PMID: 35815297 Free PMC article.
-
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35389977 Free PMC article.
-
COVID-19 vaccine-associated myocarditis.World J Cardiol. 2022 Jul 26;14(7):382-391. doi: 10.4330/wjc.v14.i7.382. World J Cardiol. 2022. PMID: 36161056 Free PMC article. Review.
References
-
- Calderon-Dominguez M, Trejo-Gutierrez E, González-Rovira A, Beltrán-Camacho L, Rojas-Torres M, Eslava-Alcón S, Sanchez-Morillo D, Calderon-Dominguez J, Martinez-Nicolás MP, Gonzalez-Beitia E, Nieto-Martín MD, Trujillo-Soto T, Rodríguez-Iglesias MA, Moreno JA, Moreno-Luna R, Durán-Ruiz MC. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients. Mol Ther Nucleic Acids. 2022;29:76–87. doi: 10.1016/j.omtn.2022.06.006. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous